PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Pharmacy, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Pathology, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Pathology, University Hospitals Leuven, Leuven, Belgium.\', \'Medical Intensive Care, University Hospitals Leuven, Leuven, Belgium.\', \'Department of Pulmonology, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Intensive Care, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.\', \'Department of Medical Microbiology, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands. Electronic address: paul.verweij@radboudumc.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(21)00138-710.1016/S2213-2600(21)00138-7
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 34051176
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all